226
Views
1
CrossRef citations to date
0
Altmetric
CASE SERIES

Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes

, , , , , & show all
Pages 1895-1902 | Received 07 Mar 2023, Accepted 03 Jun 2023, Published online: 26 Jun 2023

References

  • Ismail AA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Labor Med. 2016;54(11):1715–1724. doi:10.1515/cclm-2015-1255
  • Censi S, Albergoni MP, Gallo N, et al. Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature. Clin Chem Labor Med. 2018;56(6):889–895. doi:10.1515/cclm-2017-0392
  • Lin MX, Chen Y, Ning J, et al. Insulin autoimmune syndrome: a systematic review. Int J Endocrinol. 2023;2023:1225676. doi:10.1155/2023/1225676
  • Hu X, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients. Endocr Connect. 2018;7(1):R47–R55. doi:10.1530/EC-17-0309
  • Robbins DJ, Taylor NE, Narayanan D, et al. Therapeutic plasma exchange for exogenous insulin antibody syndrome in combined variable immunodeficiency: a case report. J Clin Apher. 2020;35(2):128–130. doi:10.1002/jca.21769
  • Fineberg SE, Kawabata TT, Finco-Kent D, et al. Immunological responses to exogenous insulin. Endocr Rev. 2007;6(6):625–652. doi:10.1210/er.2007-0002
  • Saleem M, Martin H, Coates P, et al. Prolactin biology and laboratory measurement: an update on physiology and current analytical issues. Clin Biochem. 2018;39(1):3–16. doi:10.1210/jc.2010-1692
  • Li Z, Yi D, Zheng L, et al. Analysis of the clinical characteristics of insulin autoimmune syndrome induced by exogenous insulin in diabetic patients. Diabetol Metab Syndr. 2021;13:138. doi:10.1186/s13098-021-00658-z
  • Cappellani D, Macchia E, Falorni A, et al. Insulin autoimmune syndrome (Hirata Disease): a comprehensive review fifty years after its first description. Diabetes Metabol Syndr Obesity. 2020;13:963–978. doi:10.2147/DMSO.S219438
  • Sauerborn M, Brinks V, Jiskoot W, et al. Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends Pharmacol Sci. 2010;31(2):53–59. doi:10.1016/j.tips.2009.11.001
  • Lindholm A, Jensen LB, Home PD, et al. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care. 2002;25(5):876–882. doi:10.2337/diacare.25.5.876
  • Olsen CL, Chan E, Turner DS, et al. Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems. Diabetes Care. 1994;17(3):169–176. doi:10.2337/diacare.17.3.169
  • Feingold KR. Atypical forms of diabetes. In: Feingold KR, editor. Endotext. MDText.com, Inc.; 2022.
  • Patel M, Shah R, Ramteke‐Jadhav S, et al. Management of insulin autoimmune hypoglycaemia: single-centre experience from Western India with systematic review of world literature. Clin Endocrinol (Oxf). 2020;92(5):409–420. doi:10.1111/cen.14174
  • Boro H, Gupta U, Singh C, et al. Insulin autoimmune syndrome - a case series. Eur Endocrinol. 2020;16(2):168–171. doi:10.17925/EE.2020.16.2.168
  • Sutkowska E, Ostrowska M, Sutkowska M, et al. Insulin autoimmune syndrome as part of pre-clinical LADA. Diabetes Metabol Syndr Obesity. 2021;14:1557–1561. doi:10.2147/DMSO.S302874
  • Douillard C, Jannin A, Vantyghem M-C, et al. Rare causes of hypoglycemia in adults. Annales d’endocrinologie. 2020;81(2–3):110–117. doi:10.1016/j.ando.2020.04.003
  • Okuroglu N, Sertbas M, Akkoz C, et al. Insulin autoimmune syndrome - time to remember. Endokrynol Pol. 2020;71(2):204–205. doi:10.5603/EP.a2019.0065
  • Sima A, Vlad AR, Timar B, et al. Insulin autoimmune syndrome in a young caucasian woman. Acta Endocrinol. 2021;17(2):248–250. doi:10.4183/aeb.2021.248